Federal Register / Vol. 86, No. 26 / Wednesday, February 10, 2021 / Notices 8929 

The DG, entitled, ‘‘Safety-Related 

Steel Structures and Steel-Plate 

Composite Walls for other than Reactor 

Vessels and Containments’’ is a 

proposed new guide temporarily 

identified by its task number, DG–1304. 

It proposes guidance to meet regulatory 

requirements for safety-related steel 

structures and steel-plate composite 

walls for other than reactor vessels and 

containments. It endorses with, 

exceptions and clarifications, the 2018 

edition of ANSI/AISC N690–2018, 

‘‘Specification for Safety-Related Steel 

Structures for Nuclear Facilities.’’ 

The staff is also issuing for public 

comment a draft regulatory analysis 

(ADAMS Accession No. ML20339A559). 

The staff develops a regulatory analysis 

to assess the value of issuing or revising 

a regulatory guide as well as alternative 

courses of action. 

III. Backfitting, Forward Fitting, and 

Issue Finality 

Issuance of DG–1304, if finalized, 

would not constitute backfitting as that 

term is defined in title 10 of the Code 

of Federal Regulations (10 CFR) section 

50.109, ‘‘Backfitting,’’ and as described 

in NRC Management Directive 8.4, 

‘‘Management of Backfitting, Forward 

Fitting, Issue Finality, and Information 

Requests’’; constitute forward fitting as 

that term is defined and described in 

MD 8.4; or affect issue finality of any 

approval issued under 10 CFR part 52, 

‘‘Licenses, Certificates, and Approvals 

for Nuclear Power Plants.’’ As explained 

in DG–1304, applicants and licensees 

are not required to comply with the 

positions set forth in DG–1361. 

Dated: February 4, 2021. 

For the Nuclear Regulatory Commission. 

Meraj Rahimi, 

Chief, Regulatory Guidance and Generic 

Issues Branch, Division of Engineering, Office 

of Nuclear Regulatory Research. 

[FR Doc. 2021–02720 Filed 2–9–21; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Meeting Notice 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) will convene a 

meeting of the Advisory Committee on 

the Medical Uses of Isotopes (ACMUI) 

on March 16, 2021. A sample of agenda 

items to be discussed during the public 

session includes: An overview of fiscal 

year 2020 medical related events; a 

discussion on the status of the NRC’s 

patient release evaluation of emerging 

brachytherapy sources; a discussion on 

calibration procedures for existing and 

emerging brachytherapy sources; a 

discussion on the current ACMUI 

reporting structure; and an overview on 

the consequences of 

radiopharmaceutical extravasation and 

therapeutic interventions in nuclear 

medicine. The agenda is subject to 

change. The current agenda and any 

updates will be available on the 

ACMUI’s Meetings and Related 

Documents web page at https://

www.nrc.gov/reading-rm/doccollections/acmui/meetings/2021.html 

or by emailing Ms. Kellee Jamerson at 

the contact information below. 

DATES: Date and Time for Open Session: 

Tuesday, March 16, 2021, from 10:00 

a.m. to 3:45 p.m. EST. 

ADDRESSES: 

Date Webinar information 

March 16, 

2021.

Link: https://

usnrc.webex.com. 

Event number: 199 910 

9533. 

Public Participation: Due to the 

ongoing COVID–19 public health 

emergency, the meeting will be held as 

a webinar using Cisco WebEx. Any 

member of the public who wishes to 

participate in any portion of this 

meeting should register in advance of 

the meeting by accessing the provided 

link above. Upon successful registration, 

a confirmation email will be generated 

providing the telephone bridge line and 

a link to join the webinar on the day of 

the meeting. Members of the public 

should also monitor the NRC’s Public 

Meeting Schedule at https://

www.nrc.gov/pmns/mtg for any meeting 

updates. If there are any questions 

regarding the meeting, persons should 

contact Ms. Jamerson using the 

information below. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Kellee Jamerson, email: 

Kellee.Jamerson@nrc.gov, telephone: 

301–415–7408. 

SUPPLEMENTARY INFORMATION: 

Purpose: Discuss issues related to 10 

CFR part 35 Medical Use of Byproduct 

Material. 

Conduct of the Meeting 

The ACMUI Chair, Darlene F. Metter, 

M.D., will preside over the meeting. Dr. 

Metter will conduct the meeting in a 

manner that will facilitate the orderly 

conduct of business. The following 

procedures apply to public participation 

in the meeting: 

1. Persons who wish to provide a 

written statement should submit an 

electronic copy to Ms. Jamerson using 

the contact information listed above. All 

submittals must be received by the close 

of business on March 10, 2021 and must 

only pertain to the topics on the agenda. 

2. Questions and comments from 

members of the public will be permitted 

during the meeting, at the discretion of 

the ACMUI Chairman. 

3. The draft transcript and meeting 

summary will be available on ACMUI’s 

website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 

2021.html on or about May 3, 2021. 

4. Persons who require special 

services, such as those for the hearing 

impaired, should notify Ms. Jamerson of 

their planned participation. 

This meeting will be held in 

accordance with the Atomic Energy Act 

of 1954, as amended (primarily Section 

161a); the Federal Advisory Committee 

Act (5 U.S.C. App); and the 

Commission’s regulations in Title 10 of 

the Code of Federal Regulations, Part 7. 

Dated at Rockville, Maryland this 4th day 

of February, 2021. 

For the U.S. Nuclear Regulatory 

Commission. 

Russell E. Chazell, 

Federal Advisory Committee Management 

Officer. 

[FR Doc. 2021–02688 Filed 2–9–21; 8:45 am] 

BILLING CODE 7590–01–P 

OFFICE OF PERSONNEL 

MANAGEMENT 

Submission for Review: 3206–0156, 

Application for Death Benefits Under 

the Civil Service Retirement System 

(SF 2800); Documentation in Support 

of Application for Death Benefits When 

Deceased Was an Employee at the 

Time of Death (CSRS) 

AGENCY: Office of Personnel 

Management. 

ACTION: 60-Day notice and request for 

comments. 

SUMMARY: Retirement Services, Office of 

Personnel Management (OPM) offers the 

general public and other federal 

agencies the opportunity to comment on 

a renewal with minor edits of 

information collection request (ICR), SF 

2800—Application for Death Benefits 

(CSRS) and SF 2800A—Documentation 

and Elections in Support of Application 

for Death Benefits When Deceased Was 

an Employee at the Time of Death 

(CSRS). We have updated the way we 

display the OMB control number and 

there are editorial changes to the